Literature DB >> 21743000

Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.

Robert D Gaffin1, Shamim A K Chowdhury, Marco S L Alves, Fernando A L Dias, Cibele T D Ribeiro, Rosalvo T H Fogaca, David F Wieczorek, Beata M Wolska.   

Abstract

The effects of nicotine (NIC) on normal hearts are fairly well established, yet its effects on hearts displaying familial hypertrophic cardiomyopathy have not been tested. We studied both the acute and chronic effects of NIC on a transgenic (TG) mouse model of FHC caused by a mutation in α-tropomyosin (Tm; i.e., α-Tm D175N TG, or Tm175). For acute effects, intravenously injected NIC increased heart rate, left ventricular (LV) pressure, and the maximal rate of LV pressure increase (+dP/dt) in non-TG (NTG) and Tm175 mice; however, Tm175 showed a significantly smaller increase in the maximal rate of LV pressure decrease (-dP/dt) compared with NTGs. Western blots revealed phosphorylation of phospholamban Ser16 and Thr17 residue increased in NTG mice following NIC injection but not in Tm175 mice. In contrast, phosphorylation of troponin I at serine residues 23 and 24 increased equally in both NTG and Tm175. Thus the attenuated increase in relaxation in Tm175 mice following acute NIC appears to result primarily from attenuated phospholamban phosphorylation. Chronic NIC administration (equivalent to smoking 2 packs of cigarettes/day for 4 mo) also increased +dP/dt in NTG and Tm175 mice compared with chronic saline. However, chronic NIC had little effect on heart rate, LV pressure, -dP/dt, LV wall and chamber dimensions, or collagen content for either group of mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743000      PMCID: PMC3197430          DOI: 10.1152/ajpheart.00277.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  66 in total

1.  Effects of chronic nicotine administration on RBC velocity in mesenteric capillaries of the rat.

Authors:  D Richardson; R Morton; J Howard
Journal:  Blood Vessels       Date:  1977

2.  Combined effects of cocaine and nicotine on cardiovascular performance in a canine model.

Authors:  M C Mehta; A C Jain; M D Billie
Journal:  Clin Cardiol       Date:  2001-09       Impact factor: 2.882

3.  Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.

Authors:  C C Evans; J R Pena; R M Phillips; M Muthuchamy; D F Wieczorek; R J Solaro; B M Wolska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

4.  Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction.

Authors:  M Yashima; T Ohara; J M Cao; Y H Kim; M C Fishbein; W J Mandel; P S Chen; H S Karagueuzian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

5.  Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.

Authors:  James R Peña; Ariani C Szkudlarek; Chad M Warren; Lynley S Heinrich; Robert D Gaffin; Ganapathy Jagatheesan; Federica del Monte; Roger J Hajjar; Paul H Goldspink; R John Solaro; David F Wieczorek; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2010-09-18       Impact factor: 5.000

6.  Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban.

Authors:  L K MacDougall; L R Jones; P Cohen
Journal:  Eur J Biochem       Date:  1991-03-28

7.  Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation.

Authors:  Edson Castardeli; Daniella R Duarte; Marcos F Minicucci; Paula S Azevedo; Beatriz B Matsubara; Luiz S Matsubara; Alvaro O Campana; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Eur J Heart Fail       Date:  2007-10-24       Impact factor: 15.534

8.  Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals.

Authors:  K Przyklenk
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

Review 9.  Familial hypertrophic cardiomyopathy: from mutations to functional defects.

Authors:  G Bonne; L Carrier; P Richard; B Hainque; K Schwartz
Journal:  Circ Res       Date:  1998-09-21       Impact factor: 17.367

10.  Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C.

Authors:  R Zhang; J Zhao; J D Potter
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

View more
  3 in total

1.  Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy.

Authors:  Chehade N Karam; Chad M Warren; Marcus Henze; Natasha H Banke; E Douglas Lewandowski; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

2.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

3.  Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain.

Authors:  Anat Biegon; Nelly Alia-Klein; Joanna S Fowler
Journal:  Front Pharmacol       Date:  2012-11-06       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.